Skip to Main content Skip to Navigation
Journal articles

Lack of evidence for CDK12 as an ovarian cancer predisposing gene

Abstract : CDK12 variants were investigated as a genetic susceptibility to ovarian cancer in a series of 416 unrelated and consecutive patients with ovarian carcinoma and who carry neither germline BRCA1 nor BRCA2 pathogenic variant. The presence of CDK12 variants was searched in germline DNA by massive parallel sequencing on pooled DNAs. The lack of detection of deleterious variants and the observed proportion of missense variants in the series of ovarian carcinoma patients as compared with all human populations strongly suggests that CDK12 is not an ovarian cancer predisposing gene.
Document type :
Journal articles
Complete list of metadata
Contributor : Marc-Henri STERN Connect in order to contact the contributor
Submitted on : Wednesday, December 2, 2020 - 4:52:42 PM
Last modification on : Sunday, June 26, 2022 - 2:20:31 AM
Long-term archiving on: : Wednesday, March 3, 2021 - 8:00:05 PM


Files produced by the author(s)



Alexandre Eeckhoutte, Mathilde Saint-Ghislain, Manon Reverdy, Virginie Raynal, Sylvain Baulande, et al.. Lack of evidence for CDK12 as an ovarian cancer predisposing gene. Familial Cancer, Springer Verlag (Germany), 2020, 19 (3), pp.203-209. ⟨10.1007/s10689-020-00169-2⟩. ⟨inserm-03036539⟩



Record views


Files downloads